Compositions for cosmetic and dermatological use
The invention concerns a composition for cosmetic or dermatological use comprising an iron-binding glycoprotein and a casein hydrolysate, and optionally comprising colostrum, a precursor of nitric oxide, an antioxidant and serotonin or one of the precursors thereof.
1. A composition for topical application comprising lactoferrin, α-casozepine, and carboxymethylcellulose gel, wherein the weight ratio of lactoferrin to α-casozepine is from 0.1 to 6.
2. The composition according to claim 1 , further comprising colostrum.
3. The composition according to claim 1 comprising, by weight of dry matter one or more components selected from the group consisting of:
from 2 to 30% by weight of dry matter, of actoferrin;
from 2 to 30% by weight of dry matter, of α-casozepine;
from 15 to 70% by weight of dry matter, of colostrum;
from 10 to 50% by weight of dry matter, of nitric oxide precursor;
from 2 to 30% by weight of dry matter, of antioxidant; and
from 2 to 30% by weight of dry matter, of serotonin or a precursor thereof.
4. The composition according to claim 1 comprising, by weight of dry matter one or more components selected from the group consisting of:
from 2 to 30% by weight of dry matter of lactoferrin;
from 2 to 30% by weight of dry matter of α-casozepine;
from 15 to 70% by weight of dry matter of colostrum;
from 10 to 50% by weight of dry matter of L-arginine;
from 2 to 30% by weight of dry matter of astaxanthin; and
from 2 to 30% by weight of dry matter of tryptophan.
5. The composition according to claim 1 , comprising by weight of dry matter:
from 15 to 20% of lactoferrin;
from 5 to 10% of α-casozepine;
from 25 to 45% of colostrum;
from 20 to 30% of L-arginine;
from 5 to 10% of astaxanthin; and
from 5 to 10% of tryptophan.
6. A method for cosmetic treatment of the skin, comprising topically applying to the skin the composition according to claim 1 .
7. The method according to claim 6 , wherein the cosmetic treatment of the skin is selected from the group consisting of: filling wrinkles, reducing under-eye bags, lightening under-eye dark circles, reducing age spots, increasing skin elasticity and attenuating stretch marks.
8. A method for treatment of a dermatological disease comprising administering the composition according to claim 1 to a patient in need thereof.
9. The method according to claim 8 , wherein the dermatological disease is selected from the group consisting of: skin atrophy, eczema and cheloids.
10. The composition according to claim 2 , wherein the colostrum is bovine colostrum.
11. The composition according to claim 1 , further comprising a precursor of nitric oxide.
12. The composition according to claim 11 , wherein the precursor of nitric oxide is L-arginine.
13. The composition according to claim 1 , further comprising an antioxidant.
14. The composition according to claim 13 , wherein the antioxidant is astaxanthin.
15. The composition according to claim 1 , further comprising serotonin or a precursor thereof.
16. The composition according to claim 15 , wherein the serotonin or precursor thereof is tryptophan.
17. The composition according to claim 1 comprising, by weight of dry matter one or more components selected from the group consisting of:
from 10 to 30% by weight of dry matter of actoferrin;
from 3 to 20% by weight of dry matter of α-casozepine;
from 20 to 50% by weight of dry matter of colostrum;
from 15 to 40% by weight of dry matter of nitric oxide precursor;
from 3 to 20% by weight of dry matter of antioxidant; and
from 3 to 20% by weight of dry matter of serotonin or a precursor thereof.
18. The composition according to claim 1 comprising, by weight of dry matter one or more components selected from the group consisting of:
from 10 to 30% by weight of dry matter of lactoferrin;
from 3 to 20% by weight of dry matter of α-casozepine;
from 20 to 50% by weight of dry matter of colostrum;
from 15 to 40% by weight of dry matter of L-arginine;
from 3 to 20% by weight of dry matter of astaxanthin; and
from 3 to 20% by weight of dry matter of tryptophan.